A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Clinical trial NCT05605522 · TERMINATED

Trial details

NCT number: NCT05605522
Sponsor: 3B Pharmaceuticals GmbH
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)Squamous Cell Carcinoma of Head and Neck Colorectal Cancer Gastric Cancer Ewing Sarcoma NTSR1 Expressing Solid Tumours Neuroendocrine Differentiated (NED) Prostate Cancer

Start date: 2023-02-07
Primary completion: 2024-07-19
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.